Eden Home Health Location: 4996 East Mediterranean Drive, Suite D, Sierra Vista, Arizona 85635 Ratings: Phone: (360) 892-6628 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Medical Social Services, Home Health Aide |
Bayada Home Health Care, Inc Location: 1967 South Frontage Road, Sierra Vista, Arizona 85635 Ratings: Phone: (520) 459-4800 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Trinity Visiting Nurse And Homecare, Llc Location: 4226 Avenida Cochise, Suite 5, Sierra Vista, Arizona 85635 Ratings: Phone: (520) 458-1536 Health Services: Nursing Care, Physical Therapy, Home Health Aide |
News Archive
The New York Times: Rep. Paul Ryan, "as you may have heard, is the Republican star of the moment. A 40-year-old from southeastern Wisconsin serving his sixth term in the House, Mr. Ryan has been getting a lot of attention for his 'Roadmap for America's Future,' an unusually austere proposal to vanquish the federal debt by, among other things, partly dismantling Social Security and Medicare as they currently exist."
A study performed on the NASA Space Shuttle Discovery showed that exposure of mouse embryonic stem cells (mESCs) to microgravity inhibited their ability to differentiate and generate most cell lineages, needed for the development of bone, muscle, the immune system, and other organs and tissues.
Do we need a revision of current recommendations for breast cancer screening? According to a recent prospective multicenter cohort study published in the "Journal of Clinical Oncology", this appears advisable at least for young women carrying an increased risk of breast cancer. The results of the EVA trial confirm once more that magnetic resonance imaging (MRI) is substantially more accurate for early diagnosis of breast cancer than digital mammography or breast ultrasound: MRI is three times more sensitive for breast cancer than digital mammography.
A trial on shunts used to direct blood flow to the lungs, led by researchers at the University of Michigan's C.S. Mott Children's Hospital, will lead to better outcomes for kids worldwide born with hypoplastic left heart syndrome, the most common severe heart birth defect.
Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announced today the grant of US Patent 7,807,138 entitled "Biomarkers of Metabolic Responses to Hepatic Drugs". The USPTO awarded the patent to Metabolon on October 5, 2010. This is the 13th patent issued to Metabolon and the second in its portfolio of biomarker patents.
› Verified 8 days ago